ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,3,Headache,Headaches NEC,Headaches,Nerv,N
4,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
6,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
11,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
12,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
13,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
16,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
18,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
19,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
21,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
23,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
24,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
27,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
28,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
32,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
33,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
33,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
34,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
35,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
37,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
38,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
40,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
41,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
42,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
43,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
44,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
45,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
46,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
47,2,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
50,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
51,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
52,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
53,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
54,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
55,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
56,1,Skin maceration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
57,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
58,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
60,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
62,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
63,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
64,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
64,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
65,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
67,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
68,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
68,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
68,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
68,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
70,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
70,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
72,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
73,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
76,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
76,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
77,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
78,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
78,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
79,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
80,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
81,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
82,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,2,Respiratory alkalosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
83,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
84,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
84,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
85,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
86,1,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
87,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
87,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
88,1,Headache,Headaches NEC,Headaches,Nerv,N
88,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
89,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
90,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
90,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
90,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
92,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
93,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
94,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
95,1,Deafness,Hearing losses,Hearing disorders,Ear,N
95,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
96,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
97,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
98,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Deafness,Hearing losses,Hearing disorders,Ear,N
100,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
100,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
100,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
101,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
102,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
104,1,Alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
104,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
104,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
104,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
104,5,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
105,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
105,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
106,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
107,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
109,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
110,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
110,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,1,Deafness,Hearing losses,Hearing disorders,Ear,N
111,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
112,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
112,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
113,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
113,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
114,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
114,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
115,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
115,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
116,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
118,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
118,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
118,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
119,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
120,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
122,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
122,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
122,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
123,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
124,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
125,2,Headache,Headaches NEC,Headaches,Nerv,N
125,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
127,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
127,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
128,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
128,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
130,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
131,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
134,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
135,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
135,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
135,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
135,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
137,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
138,1,Reye's syndrome,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
139,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
139,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,4,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
140,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
140,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
140,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
140,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
141,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
142,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,1,Reye's syndrome,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
144,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
145,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
147,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
148,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
151,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
152,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
153,1,Acne,Acnes,Skin appendage conditions,Skin,N
154,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
155,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
157,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
160,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
162,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
163,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
164,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
165,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
165,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
166,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
166,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
167,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
168,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
169,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
170,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
170,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
170,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
172,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
173,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
173,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
174,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
176,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
176,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
178,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
179,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
180,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
181,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
182,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
182,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
182,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
183,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
183,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
185,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
186,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
189,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
190,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
190,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
190,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
190,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
191,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
192,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
193,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
194,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
195,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
195,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
196,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
197,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
197,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
199,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
200,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
201,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
202,1,Application site coldness,Application site reactions,Administration site reactions,Genrl,N
202,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
202,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
202,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
203,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
203,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
205,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
206,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
207,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
208,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
208,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
208,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
209,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
210,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
210,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
211,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
211,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
211,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
212,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
213,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
213,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
214,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
215,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
215,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
215,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
217,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
217,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
217,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
217,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
217,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
217,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
218,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
219,1,Gingival blister,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
219,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
220,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
220,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
221,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
221,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
222,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
222,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
222,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
223,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
223,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
223,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
223,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
223,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
223,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
224,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
225,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
226,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
226,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
227,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
227,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
227,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
227,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
227,6,Reye's syndrome,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
227,7,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
228,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
228,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
229,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
229,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
230,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
231,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
231,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
232,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
233,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
234,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
235,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
236,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
236,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
237,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
239,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
239,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
239,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
240,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
241,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
241,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
241,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
241,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
242,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
242,3,Mucosal pain,Mucosal findings abnormal,General system disorders NEC,Genrl,N
242,4,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
243,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
243,2,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
244,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
244,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
244,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
244,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
244,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
245,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
245,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
246,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
246,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
246,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
246,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
246,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
247,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
248,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
248,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
249,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
250,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
250,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
250,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
250,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
250,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
251,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
251,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
252,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
252,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
252,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
252,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
252,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
253,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
254,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
254,2,Headache,Headaches NEC,Headaches,Nerv,N
254,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
256,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
257,1,Glucose tolerance test abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,Y
258,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
258,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
259,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
259,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
259,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
259,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
259,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
260,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
261,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
261,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
262,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
263,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
264,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
265,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
267,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
268,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
269,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
270,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
271,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
273,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
274,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
274,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
274,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
274,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
275,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
276,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
276,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
277,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
278,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
278,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
278,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
278,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
279,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
279,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
280,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
280,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
281,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
281,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
281,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
281,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
282,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
283,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
284,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
284,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
284,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
284,4,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
284,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
284,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
284,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
284,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
284,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
285,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
285,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
285,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
285,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
286,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
286,2,Brain natriuretic peptide abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
286,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
286,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
286,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
286,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
286,7,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
287,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
287,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
288,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
288,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
288,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
288,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
288,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
289,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
289,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
290,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
291,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
291,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
291,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
292,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
292,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
293,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
293,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
294,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
294,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
294,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
295,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
296,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
296,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
297,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
297,3,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
297,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
297,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
298,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
298,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
298,4,Headache,Headaches NEC,Headaches,Nerv,N
298,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
298,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
298,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
299,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
299,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
299,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
299,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
299,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,6,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
299,7,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
299,8,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
299,9,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
299,10,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
299,11,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
299,12,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
299,13,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
299,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
299,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
299,16,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,17,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
299,18,Reye's syndrome,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
299,19,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
299,20,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
299,21,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
299,22,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
299,23,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
299,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Epiglottis ulcer,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
300,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
300,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
301,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
302,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
302,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
303,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
303,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
304,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
305,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
306,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
306,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
307,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
307,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
307,4,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
307,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
307,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
307,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
309,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
309,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
310,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
311,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
311,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
311,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
312,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
312,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
312,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
312,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
312,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
313,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
313,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
313,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
313,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
313,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
314,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
315,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
316,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
317,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
317,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
317,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
317,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
317,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
318,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
318,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
319,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
319,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
319,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
320,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
320,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
320,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
321,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
321,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
321,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
322,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
323,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
323,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
323,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
324,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
325,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
325,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
325,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
326,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
326,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
326,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
326,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
326,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
327,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
327,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
328,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
328,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
328,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
329,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
330,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
332,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
332,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
332,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
333,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
334,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
334,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
334,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
334,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
334,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
334,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
334,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,9,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
334,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
335,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
335,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
335,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
335,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
335,5,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
336,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
336,2,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
336,3,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
336,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
337,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
337,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
337,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
338,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
338,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
338,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
338,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
338,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
339,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
339,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
339,3,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
339,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
339,5,Fluid intake restriction,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
339,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
339,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
340,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
340,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
341,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
342,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
342,2,Headache,Headaches NEC,Headaches,Nerv,N
342,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
342,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,5,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
342,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
343,1,Gingival discomfort,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
343,2,Gingival erythema,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
344,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
344,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
344,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
344,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Application site joint erythema,Application site reactions,Administration site reactions,Genrl,N
345,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
345,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
345,4,Headache,Headaches NEC,Headaches,Nerv,N
345,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
345,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
345,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
345,8,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
346,1,Application site joint erythema,Application site reactions,Administration site reactions,Genrl,N
346,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
346,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
346,4,Headache,Headaches NEC,Headaches,Nerv,N
346,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
346,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
346,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
346,8,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
347,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
348,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
348,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
348,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
348,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
349,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
349,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
349,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
350,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
350,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
351,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
351,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
351,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
352,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
352,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
352,3,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
352,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
352,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
353,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
353,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
353,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
354,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
355,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
355,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
355,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
356,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
356,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
356,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
356,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
357,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
357,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
358,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
358,2,Skin degenerative disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
359,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
359,2,Application site injury,Application site reactions,Administration site reactions,Genrl,N
359,3,Device leakage,Device issues NEC,Device issues,Prod,N
359,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
360,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
361,1,Device interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
362,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
363,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
363,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
363,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
364,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
364,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
365,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
365,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
365,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
366,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
366,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
367,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
367,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
368,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
369,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
370,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
370,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
371,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
372,1,Excessive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
373,1,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
373,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
373,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
374,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
375,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
376,1,Administration site erosion,Administration site reactions NEC,Administration site reactions,Genrl,N
376,2,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
377,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
379,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
380,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
382,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
382,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
383,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
384,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
385,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
386,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
387,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
387,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
387,3,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
388,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
389,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
390,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
391,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
392,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
392,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
392,3,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
393,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
394,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
395,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
395,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
396,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
396,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
396,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
396,5,Tongue pruritus,Tongue signs and symptoms,Tongue conditions,Gastr,N
396,6,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
396,7,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
396,8,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
397,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
398,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
398,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
398,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
398,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
399,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
400,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
401,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
402,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
402,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
402,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
402,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
402,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
402,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
402,8,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
402,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
402,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
403,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
403,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
404,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
404,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
404,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
405,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
405,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
406,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
406,3,Tongue injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
406,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
407,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
408,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
409,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
409,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
410,1,Gingival blister,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
410,2,Gingival discomfort,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
411,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
412,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
412,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
412,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
412,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
413,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
414,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
414,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
414,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
414,4,Product contamination chemical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
415,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
416,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
417,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
417,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
418,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
419,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
420,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
420,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
421,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
421,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
422,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
423,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
423,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
423,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
423,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
424,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
424,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
424,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
424,4,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
424,5,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
424,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
424,7,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
425,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
425,2,Application site induration,Application site reactions,Administration site reactions,Genrl,N
426,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
426,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
427,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
427,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
427,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
428,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
429,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
430,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
431,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
431,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
432,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
432,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
432,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
432,4,Headache,Headaches NEC,Headaches,Nerv,N
432,5,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
432,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
433,2,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
434,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
435,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
435,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
436,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
437,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
437,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
437,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
438,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
438,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
439,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
439,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
440,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
440,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
441,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
442,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
442,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
443,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
443,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
443,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
443,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
443,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
444,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
445,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
446,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
447,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
448,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
448,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
448,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
449,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
450,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
450,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
451,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
451,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
451,3,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
452,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
452,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
452,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
452,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
453,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
453,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
453,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
454,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
455,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
456,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
457,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
457,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
458,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
459,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
459,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
460,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
461,1,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
462,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
462,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
463,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
463,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
464,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
464,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
464,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
465,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
465,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
465,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
465,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
465,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
466,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
466,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
466,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
467,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
467,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
468,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
468,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
469,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
469,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
470,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
470,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
471,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
471,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
472,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
473,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
473,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
473,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
474,1,Administration site exfoliation,Administration site reactions NEC,Administration site reactions,Genrl,N
474,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
475,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
476,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
476,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
476,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
476,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
476,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
476,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
477,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
477,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
478,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
479,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
480,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
481,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
481,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
482,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
482,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
482,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
483,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
484,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
484,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
484,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
484,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
485,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
485,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
486,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
486,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
487,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
488,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
488,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
488,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
488,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
489,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
489,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
489,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
490,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
490,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
491,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
491,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
492,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
492,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
492,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
492,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
493,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
493,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
494,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
494,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
494,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
495,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
496,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
496,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
497,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
498,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
498,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
498,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
499,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
499,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
500,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
500,2,Hair dye user,Social issues NEC,Lifestyle issues,SocCi,N
501,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
501,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
502,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
502,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
503,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
504,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
504,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
505,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
506,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
507,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
508,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
509,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
510,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
511,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
511,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
512,1,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
512,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
513,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
513,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
513,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
513,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
514,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
515,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
515,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
515,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
516,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
516,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
517,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
518,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
519,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
520,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
521,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
522,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
523,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
524,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
525,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
525,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
526,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
526,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
526,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
526,5,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
526,6,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
526,7,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
527,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
528,1,Cerebellar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
528,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
529,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
529,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
529,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
530,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
530,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
531,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
531,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
534,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
534,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
534,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
534,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,1,Corneal toxicity,Corneal injuries,Ocular injuries,Eye,N
536,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
537,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
537,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
538,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
539,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
539,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
539,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
539,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
539,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
539,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
539,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
540,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
541,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
541,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
541,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
542,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
543,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
543,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
544,2,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
544,3,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
545,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
546,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
546,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
546,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
547,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
547,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
548,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
550,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
550,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
551,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
551,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
552,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
554,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
555,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
555,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
556,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
556,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
557,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
558,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
559,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
560,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
560,2,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
561,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
562,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
563,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
563,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
563,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
564,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
564,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
565,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
565,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
567,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
568,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
569,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
570,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
570,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
570,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
571,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
572,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
573,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
574,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
574,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
575,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
576,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
576,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
576,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
577,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
578,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
578,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
579,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
579,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
580,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
581,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
582,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
583,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
583,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
583,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
584,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
585,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
586,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
587,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
587,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
588,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
589,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
590,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
590,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
590,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
590,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
591,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
591,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
591,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
591,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
592,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
593,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
593,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
593,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
594,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
594,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
595,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
596,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
596,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
597,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
598,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
599,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
600,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
600,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
600,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
601,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
602,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
602,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
603,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
603,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
604,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
605,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
605,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
605,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
606,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
606,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
606,3,Product selection error,Product selection errors and issues,Medication errors and other product use errors and issues,Inj&P,N
607,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
607,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
607,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
608,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
609,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
609,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
610,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
610,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
611,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
612,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
613,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
614,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
614,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
615,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
615,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
615,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
616,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
616,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
617,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
617,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
618,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
619,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
620,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
620,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
620,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
621,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
621,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
621,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
621,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
622,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
623,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
624,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
624,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
625,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
625,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
625,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
626,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
626,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
627,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
628,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
628,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
629,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
629,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
630,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
631,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
631,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
631,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
632,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
632,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
634,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
634,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
634,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
635,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
635,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
636,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
636,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
637,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
638,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
638,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
639,1,Capripox viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
639,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
639,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
639,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
640,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
640,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
640,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
642,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
642,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
642,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
642,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
643,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
644,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
645,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
645,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
646,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
646,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
646,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
647,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
647,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
647,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
647,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
648,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
649,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
649,2,Product packaging difficult to open,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
649,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
650,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
651,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
651,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
652,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
653,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
653,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
653,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
653,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
654,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
654,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
654,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
655,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
656,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
656,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
657,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
658,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
659,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
660,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
661,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
662,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
662,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
663,1,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
664,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
665,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
666,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
666,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
667,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
667,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
668,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
668,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
669,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
669,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
670,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
670,2,Application site scar,Application site reactions,Administration site reactions,Genrl,N
670,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
671,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
672,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
672,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
673,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
674,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
675,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
675,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
676,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
676,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
677,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
677,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
678,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
680,3,Pityriasis,Scaly conditions,Epidermal and dermal conditions,Skin,N
680,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
680,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
681,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
682,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
682,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
683,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
683,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
684,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
685,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
686,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
686,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
687,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
688,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
690,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
690,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
691,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
692,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
692,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
692,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
694,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
694,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,1,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
695,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
